Cepheid (CPHD) Misses Q3 EPS by 1c, Raises FY EPS Guidance

Go back to Cepheid (CPHD) Misses Q3 EPS by 1c, Raises FY EPS Guidance

Cepheid (CPHD) PT Cut to $39 at Leerink Partners

October 21, 2015 8:00 AM EDT

Leerink Partners analyst Dan Leonard reiterated a Market Perform rating and lowered his price target on Cepheid (NASDAQ: CPHD) to $39.00 (from $44.00) following third quarter results.

Leonard commented, "We are lowering our EPS estimates following the release of CPHDs full Q3 operating results,... More

Needham & Company Downgrades Cepheid (CPHD) to Hold

October 21, 2015 7:40 AM EDT

Needham & Company downgraded Cepheid (NASDAQ: CPHD) from Buy to Hold.

Analyst Mike Matson commented, "CPHD's 3Q15 results were consistent with its 10/13/15 preannouncement. Management reiterated the revenue guidance issued with the preannouncement and, not surprisingly, lowered its EPS guidance (which hadn't been updated with... More

UPDATE: Canaccord Genuity Downgrades Cepheid (CPHD) to Hold

October 21, 2015 6:47 AM EDT

(Updated - October 21, 2015 9:03 AM EDT)

Canaccord Genuity downgraded Cepheid (NASDAQ: CPHD) from Buy to Hold with a price target of $34.00 (from $42.00).

Canaccord Genuity analyst Mark Massaro said, "Cepheid went to great lengths on its Q3 call to affirm its commitment to... More

Evercore ISI Upgrades Cepheid (CPHD) to Hold

October 21, 2015 6:46 AM EDT

Evercore ISI upgraded Cepheid (NASDAQ: CPHD) from Sell to Hold with a price target of $32.50 (from $44.50).

For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.

Shares of Cepheid closed at $32.25 yesterday.

... More